| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/08/1997 | US5618975 Process for the preparation of biphenyl derivatives |
| 04/08/1997 | US5618968 N-substituted derivatives of N-methyl-3-(p-trifluoromethylphenoxy)-3-phenylpropylamine and the procedure for their preparation |
| 04/08/1997 | US5618947 Separating the racemic mixture by chromatography |
| 04/08/1997 | US5618941 Benzenealkanoic acids for cardiovascular diseases |
| 04/08/1997 | US5618939 Reacting of an amine nucleophile with an activated glycidylcompound in presence of a strong base at low temperature |
| 04/08/1997 | US5618938 Process for preparing stereo isomers of neurokinin receptor antagonists |
| 04/08/1997 | US5618928 Triazenyl-substituted phenyl pyrimidines and their use in therapy |
| 04/08/1997 | US5618850 Hydroxy-acid cosmetics |
| 04/08/1997 | US5618849 Picornavirus, enterovirus, polio virus, coxsackie virus, echo virus |
| 04/08/1997 | US5618848 Beta-agonists as an aid to maintain or enhance strength and endurance |
| 04/08/1997 | US5618847 Medicinal feed for the systemic treatment of ectoparasitic and ectobacterial diseases of fish |
| 04/08/1997 | US5618846 Treatment method for cancer |
| 04/08/1997 | US5618845 Acetamide derivative having defined particle size |
| 04/08/1997 | US5618844 Matrix metalloproteinase inhibitor |
| 04/08/1997 | US5618843 Inhibit platelet aggregation |
| 04/08/1997 | US5618842 N-acyl derivatives of aminoalcohols with polycarboxylic acids able to modulate mast cells in inflammatory processes having neuroimmunogenic origin |
| 04/08/1997 | US5618841 Includes an antimicrobial acid buffer |
| 04/08/1997 | US5618840 Prevention growth of helicobacter |
| 04/08/1997 | US5618839 Retinoid-like compounds |
| 04/08/1997 | US5618837 PDGF antagonists III |
| 04/08/1997 | US5618835 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 04/08/1997 | US5618834 Indole derivatives in the treatment of emesis |
| 04/08/1997 | US5618833 1-benzyl-1,3-dihydroindol-2-one derivatives, their preparation and the pharmaceutical compositions in which they are present |
| 04/08/1997 | US5618831 Composition and method for treating cancer |
| 04/08/1997 | US5618828 Methods for treating gastro-esophageal reflux disease and emesis with optically pure (-) cisapride |
| 04/08/1997 | US5618825 Combinatorial sulfonamide library |
| 04/08/1997 | US5618824 Treatment of obsessive-compulsive disorders with 5-HT2 antagonists |
| 04/08/1997 | US5618823 Glutathione as chemoprotective agent |
| 04/08/1997 | US5618820 1,3-oxathiolane nucleoside analogues and methods for using same |
| 04/08/1997 | US5618819 1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-(3H)-one compounds |
| 04/08/1997 | US5618817 Use of diphenylbutyl-piperazinecarboxamides in the treatment of substance disorders |
| 04/08/1997 | US5618816 Antimigraine 1,2,5-thiadiazole derivatives of indolylalkyl-pyridnyl and pyrimidinylpiperazines |
| 04/08/1997 | US5618815 1,9-bridged thiazolo[3,2-a]quinoline derivatives |
| 04/08/1997 | US5618814 Trisubstituted pyrimido [5,4-d] pyrimidines for modulating multi-drug resistance and pharmaceutical compositions containing these compounds |
| 04/08/1997 | US5618812 Benzodiazepine derivatives |
| 04/08/1997 | US5618811 Gastrointestinal and central nervous system disorders |
| 04/08/1997 | US5618808 Benzothiazepine and benzoxazepine derivatives as cholecystokinin receptor antagonists |
| 04/08/1997 | US5618806 Steroid 5alpha-reductase inhibitor; useful for treating benign prostatic hypertrophy, baldness, acne, vulguris, seborrhea, female hirsutism, and prostatic adenocarcinoma |
| 04/08/1997 | US5618805 19-nor-vitamin D compounds |
| 04/08/1997 | US5618803 Targeted drug delivery via phosphonate derivatives |
| 04/08/1997 | US5618801 Administering substituted dialkoxyphosphinoylmethylbenzamide |
| 04/08/1997 | US5618799 Storage stability, noncaking, nonscattering, adhesion |
| 04/08/1997 | US5618798 Use of sucralfate to treat baldness |
| 04/08/1997 | US5618794 α-glycosyl derivative of catecholamine or its salt, and its preparation and uses |
| 04/08/1997 | US5618698 Growing host cells transformed or transfected with specified isolated dna sequence, isolating erythropoietin product |
| 04/08/1997 | US5618662 Intravenous administration of psoralen |
| 04/08/1997 | US5618564 Composition for the treatment of helicobacter pylori infection |
| 04/08/1997 | US5618563 Encapsulating an anesthetic drug into biocompatiable microparticles |
| 04/08/1997 | US5618559 Method of making modified-release metronidazole compositions |
| 04/08/1997 | US5618558 Fatty acid treatment |
| 04/08/1997 | US5618557 Prophylactic treatment of allergic contact dermatitis |
| 04/08/1997 | US5618555 Percutaneous absorption preparation |
| 04/08/1997 | US5618553 Contacting localized region of eye with polymer implant having reversibly associated modulating agent which is released at rate such that target cells are primarily affected |
| 04/08/1997 | US5618549 Bone diseases such as osteoporosis |
| 04/08/1997 | US5618545 Skin-cosmetic composition |
| 04/08/1997 | US5618539 Aqueous solution comprising a heat resist stabilizer lysine or/and arginine |
| 04/08/1997 | US5618538 Separating clippings form plants, drying, extracting with solvent, evaporating to form residue and partitioning between water and organic layer, removing aqueous layer, evaporating |
| 04/08/1997 | US5618530 Quartenary polyallylamine |
| 04/08/1997 | US5618529 Applying mixture of copolymers of alkyl vinyl ether and maleic acid or derivatives thereof, overcoating with ointment layer, removing and reapplying overcoat layer during diaper changes without disturbing underlayer |
| 04/08/1997 | US5618527 Calcium polycarbophil sprinkle |
| 04/08/1997 | US5618519 Soluble melanin |
| 04/08/1997 | US5618516 Composition also containing water, thickener, emulsifier, propellant; applied as foam for maximum penetration |
| 04/08/1997 | CA2137164C A new composition containing selegiline |
| 04/08/1997 | CA2113566C Benzimidazole anthelmintic agents |
| 04/08/1997 | CA2091360C Mometasone furoate monohydrate, process for making same and pharmaceutical compositions |
| 04/08/1997 | CA2091204C Antiischemic-piperazinyl and piperidinyl-cyclohexanes |
| 04/03/1997 | WO1997012246A1 Tumour-specific p450 protein |
| 04/03/1997 | WO1997012060A1 ARF-p19, A NOVEL REGULATOR OF THE MAMMALIAN CELL CYCLE |
| 04/03/1997 | WO1997012057A1 Chemotherapeutic agents for mycobacterium |
| 04/03/1997 | WO1997012055A1 Product and process to regulate actin polymerization |
| 04/03/1997 | WO1997012051A1 Pharmaceutical composition useful for nucleic acid transfection, and use thereof |
| 04/03/1997 | WO1997012050A1 Method for transferring genes to the heart using aav vectors |
| 04/03/1997 | WO1997012042A2 Glycoprotein b of the rfhv/kshv subfamily of herpes viruses |
| 04/03/1997 | WO1997012041A1 SHORT FORMS OF CHEMOKINE β-8 |
| 04/03/1997 | WO1997012038A1 Novel peptides useful in enhancement of fsh action |
| 04/03/1997 | WO1997012037A1 A novel haemopoietin receptor and genetic sequences encoding same |
| 04/03/1997 | WO1997012036A2 Bone stimulating factor |
| 04/03/1997 | WO1997011968A2 A gene associated with liver neoplastic disease |
| 04/03/1997 | WO1997011965A1 Method for treating alzheimer's disease using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 04/03/1997 | WO1997011964A1 Truncated glial cell line-derived neurotrophic factor |
| 04/03/1997 | WO1997011963A1 ANTI-GALα(1,3)GAL ANTIBODY BINDING PEPTIDES |
| 04/03/1997 | WO1997011960A1 Antagonists of endothelin receptors |
| 04/03/1997 | WO1997011956A1 IDENTIFICATION OF sel-12 AND USES THEREOF |
| 04/03/1997 | WO1997011950A1 Metal complexes as cysteine protease inhibitors |
| 04/03/1997 | WO1997011940A1 Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation |
| 04/03/1997 | WO1997011720A1 Methods for treating cancers and restenosis with p21 |
| 04/03/1997 | WO1997011718A1 Inhibitors of integrin receptors and their therapeutical uses |
| 04/03/1997 | WO1997011716A1 Manipulation of non-terminally differentiated cells using the notch pathway |
| 04/03/1997 | WO1997011715A1 Mimicking peptides in cancer therapy |
| 04/03/1997 | WO1997011714A1 Chemokine inhibitor |
| 04/03/1997 | WO1997011711A1 Iron dextran formulations |
| 04/03/1997 | WO1997011710A1 Use of hyaluronic acid as an immunosuppressant |
| 04/03/1997 | WO1997011709A1 Anthelmintic macrocyclic lactone compositions |
| 04/03/1997 | WO1997011708A1 Method for treating alcoholic liver disease |
| 04/03/1997 | WO1997011707A1 Modified ether glyceroglycolipids |
| 04/03/1997 | WO1997011706A1 Use of sphingosylphosphorylcholine as a wound-healing agent |
| 04/03/1997 | WO1997011704A1 Substituted pyrazolyl benzenesulfonamides for use in veterinary therapies as antiinflammatory agents |
| 04/03/1997 | WO1997011703A1 Preventive or remedy for hyperthyreosis |
| 04/03/1997 | WO1997011702A1 Method of preventing androgenetic alopecia with 5-alpha reductase inhibitors |
| 04/03/1997 | WO1997011701A1 Compositions for treating inflammation containing certain prostaglandins and a selective cyclooxygenase-2 inhibitor |